The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
Abstract
PURPOSE: To determine the safety and efficacy of arsenic trioxide (ATO) in patients with relapsed acute promyelocytic leukemia (APL). PATIENTS AND METHODS: Forty patients experiencing first (n = 21) or ≥ second (n = 19) relapse were treated with daily infusions of ATO to a maximum of 60 doses or until all leukemic cells in bone marrow were eliminated. Patients who achieved a complete remission (CR) were offered one consolidation course of ATO that began 3 to 4 weeks later. Patients who remained in CR were eligible to receive further cycles of ATO therapy on a maintenance study. RESULTS: Thirty-four patients (85%) achieved a CR. Thirty-one patients (91%) with CRs had posttreatment cytogenetic tests negative for t(15;17). Eighty-six percent of the patients who were assessable by reverse transcriptase polymerase chain reaction converted from positive to negative for the promyelocytic leukemia/retinoic acid receptor-alpha transcript by the completion of their consolidation therapy. Thirty-two patients received consolidation therapy, and 18 received additional ATO as maintenance. Eleven patients underwent allogeneic (n = 8) or autologous (n = 3) transplant after ATO treatment. The 18-month overall and relapse-free survival (RFS) estimates were 66% and 56%, respectively. Twenty patients (50%) had leukocytosis (> 10,000 WBC/μL) during induction therapy. Ten patients developed signs or symptoms suggestive of the APL syndrome and were effectively treated with dexamethasone. Electrocardiographic QT prolongation was common (63%). One patient had an absolute QT interval of > 500 msec and had an asymptomatic 7-beat run of torsades de pointe. Two patients died during induction, neither from drug-related causes. CONCLUSION: This study establishes ATO as a highly effective therapy for patients with relapsed APL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Self-citationde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391901 · Cited by 1,213
Self-citationAll-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
Self-citationWarrell, R. P., de The, H., Wang, Z.-Y., & Degos, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290307 · Cited by 776
Self-citationHe, L.-Z., Figueiredo-Pontes, L. L., Rego, E. M., & Pandolfi, P. P. (2015) · Encyclopedia of Cancer · doi:10.1007/978-3-662-46875-3_63 · Cited by 766
Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J.-J., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1192 · Cited by 754
Vahdat, L., Maslak, P., Miller, W. J., Eardley, A., Heller, G., Scheinberg, D., & Warrell, R. J. (1994) · Blood · doi:10.1182/blood.v84.11.3843.bloodjournal84113843 · Cited by 296
Self-citationMiller, W. H., Kakizuka, A., Frankel, S. R., Warrell, R. P., DeBlasio, A., Levine, K., Evans, R. M., & Dmitrovsky, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2694 · Cited by 256
Self-citationTherapy of Molecular Relapse in Acute Promyelocytic Leukemia
Coco, F. L., Diverio, D., Avvisati, G., Petti, M. C., Meloni, G., Pogliani, E. M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., et al. (1999) · Blood · doi:10.1182/blood.v94.7.2225.419k03_2225_2229 · Cited by 229
Ohnishi, K., Yoshida, H., Shigeno, K., Nakamura, S., Fujisawa, S., Naito, K., Shinjo, K., Fujita, Y., Matsui, H., Takeshita, A., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-11-200012050-00012 · Cited by 209
Huang, W., Sun, G., Li, X., Cao, Q., Lu, Y., Jang, G., Zhang, F., Chai, Jr., Wang, Z., & Waxman, S. (1993) · Blood · doi:10.1182/blood.v82.4.1264.1264 · Cited by 189
The unique aspects of acute promyelocytic leukemia.
Stone, R. M., & Mayer, R. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1913 · Cited by 177
Self-citationCamacho, L. H., Soignet, S. L., Chanel, S., Ho, R., Heller, G., Scheinberg, D. A., Ellison, R., & Warrell, R. P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2620 · Cited by 174
Self-citationGallagher, R. E., Willman, C. L., Slack, J. L., Andersen, J. W., Li, Y., Viswanatha, D. S., Bloomfield, C. D., Appelbaum, F. R., Schiffer, C. A., Tallman, M. S., et al. (1997) · Blood · doi:10.1182/blood.v90.4.1656.1656_1656_1663 · Cited by 122
Self-citationTransgenic expression of PML/RARalpha impairs myelopoiesis.
Early, E., Moore, M. A., Kakizuka, A., Nason-Burchenal, K., Martin, P., Evans, R. M., & Dmitrovsky, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7900 · Cited by 110
Jurcic, J. G., Nimer, S. D., Scheinberg, D. A., DeBlasio, T., Warrell, R. P., & Miller, W. H. (2001) · Blood · doi:10.1182/blood.v98.9.2651 · Cited by 107
Self-citationThomas, X., Dombret, H., Cordonnier, C., Pigneux, A., Gardin, C., Guerci‐Bresler, A., Vekhoff, A., Sadoun, A., Stamatoullas, A., Fegueux, N., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401800 · Cited by 99
Soignet, S. L., Fleischauer, A. T., Polyak, T., & Heller, G. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051057 · Cited by 71
Self-citation
Cited by
Heavy Metal Toxicity and the Environment
Tchounwou, P. B., Yedjou, C. G., Patlolla, A. K., & Sutton, D. J. (2012) · Experientia Supplementum · doi:10.1007/978-3-7643-8340-4_6 · Cited by 7,192
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
Acute promyelocytic leukemia: from highly fatal to highly curable
Wang, Z.-Y., & Chen, Z. (2008) · Blood · doi:10.1182/blood-2007-07-102798 · Cited by 1,277
Metadata
- Authors
- Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian, H., Calleja, E., Stone, R. M., Kalaycio, M., Scheinberg, D. A., Steinherz, P., Sievers, E. L., Coutré, S., Dahlberg, S., Ellison, R., & Warrell, R. P.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-09-15
- Volume
- 19
- Issue
- 18
- Pages
- 3852-3860
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1931891535
- Cited by
- 826
- References
- 23
- FWCI
- 17.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.